Moving catheter ablation forward from paroxysmal to persistent atrial fibrillation: progress, limitations, and surprises of the SARA trial

Eur Heart J. 2014 Feb;35(8):482-4. doi: 10.1093/eurheartj/eht504. Epub 2013 Dec 25.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anti-Arrhythmia Agents / therapeutic use*
  • Atrial Fibrillation / therapy*
  • Catheter Ablation / methods*
  • Female
  • Humans
  • Male

Substances

  • Anti-Arrhythmia Agents